Thursday, October 9, 2025

Latest

Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising results of the company’s proprietary BMB-101 drug to treat a rare form of epilepsy, Dravet Syndrome. The chief officer also talks about the firm’s plan to list on the Nasdaq, the common misconceptions on psychedelics, and the overall outlook of the biotech company in the medical space.

Bright Minds is focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain. Bright Minds has a portfolio of next generation serotonin agonists designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. The company is developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious drugs.


FULL DISCLOSURE: Bright Minds Biosciences is a client of Canacom Group, the parent company of The Deep Dive. The company has been compensated to cover Bright Minds Biosciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

First Majestic Posts Record Quarterly Silver Production In Q3

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

Related News

$30,000 GOLD: How Trump’s Policies Could Trigger The Next Price Explosion | Simon Marcotte

In this interview, Simon Marcotte, CEO of Northern Superior Resources (TSXV: SUP), presents a bold...

Saturday, May 10, 2025, 11:31:00 AM

Zinc’s Long-Term Growth & Potential In North America — With Ritch Wigham of Slave Lake Zinc

Joining us today on The Daily Dive is Ritch Wigham, CEO & Director of Slave...

Thursday, December 22, 2022, 01:30:00 PM

Are Lithium Prices Sustainable? – The Daily Dive

Returning to the Daily Dive today is Michael Dehn, President and CEO of United Lithium...

Friday, March 11, 2022, 01:30:00 PM

A Possible NFT Crackdown From China? – The Daily Dive

Frank Holmes of US Global Investors and Hive Blockchain (TSXV: HIVE) joins us on the...

Friday, November 12, 2021, 01:30:00 PM

Staude: Bullish On Gold, Bearish On Copper? – The Daily Dive

On today’s Daily Dive, we welcome back John-Mark Staude, CEO of Riverside Resources (TSXV: RRI)....

Wednesday, February 9, 2022, 01:30:00 PM